I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effect..:
Todd A. Braciak
;
Claudia C. Roskopf
;
Sarah Wildenhain
...
http://dx.doi.org/10.1080/2162402X.2018.1472195. , 2018
Link:
https://doi.org/10.1080/2162402X.2018.1472195
RT Journal T1
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:9c33b3300b544ab9bf536064eecde761&Exemplar=1&LAN=DE A1 Todd A. Braciak A1 Claudia C. Roskopf A1 Sarah Wildenhain A1 Nadja C. Fenn A1 Christian B. Schiller A1 Ingo A. Schubert A1 Uwe Jacob A1 Annemarie Honegger A1 Christina Krupka A1 Marion Subklewe A1 Karsten Spiekermann A1 Karl-Peter Hopfner A1 Georg H. Fey A1 Michael Aigner A1 Stefan Krause A1 Andreas Mackensen A1 Fuat S. Oduncu PB Taylor & Francis Group YR 2018 K1 immunotherapy K1 aml K1 cd33-cd16-cd123 K1 dual targeting K1 single-chain triplebodies K1 nk cells K1 redirected lysis K1 therapeutic antibodies K1 Immunologic diseases. Allergy K1 RC581-607 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://dx.doi.org/10.1080/2162402X.2018.1472195 LK http://dx.doi.org/https://doi.org/10.1080/2162402X.2018.1472195 DO https://doi.org/10.1080/2162402X.2018.1472195 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)